Literature DB >> 175276

Transiently reduced activity of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of children with Reye's syndrome.

T Brown, G Hug, L Lansky, K Bove, A Scheve, M Ryan, H Brown, W K Schubert, J C Partin, J Lloyd-Still.   

Abstract

Since Reye's syndrome is associated with hyperammonemia, we measured the urea-cycle enzymes in hepatic tissue of 13 patients. Expressed as nanomoles of citrulline per milligram of hepatic protein per minute, mean activity of carbamyl phosphate synthetase (6.27 +/- 2.45 S.D.) and ornithine transcarbamylase (136.19 +/- 41.83) in Reye's syndrome was reduced significantly (P less than 0.005) when compared with that of 25 "normal" controls (11.54 +/- 4.24 and 307.49 +/- 94.15, respectively). Activity was maximally reduced during the first days of clinical symptoms; it returned toward normal during the following week regardless of whether the disease ended in death or recovery. The activity of the two enzymes was normal in patients with salicylate intoxication or heritable argininosuccinic acid synthetase deficiency. The apparent Km of hepatic ornithine transcarbamylase for ornithine was in the normal range in patients with Reye's syndrome (mean 0.24 mM). These observations indicate that Reye's syndrome is associated with acquired and transient dysfunction of hepatic mitochondrial urea-cycle enzymes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175276     DOI: 10.1056/NEJM197604152941602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

1.  Neonatal hyperammonaemia with complete absence of liver carbamyl phosphate synthetase activity.

Authors:  S Mantagos; S Tsagaraki; E A Burgess; V Oberholzer; T Palmer; J Sacks; S Baibas; T Valaes
Journal:  Arch Dis Child       Date:  1978-03       Impact factor: 3.791

Review 2.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  Liver pathology in transient neonatal hyperammonemia.

Authors:  A Zimmermann; C Bachmann; I Högger; J Gehler; A Mielfried; E Mönch; H Peters
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

4.  Management of Reye's syndrome: a rational approach to a complex problem.

Authors:  A P Sarnaik
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

5.  Adult Reye's syndrome.

Authors:  S A Al-Tikriti; P A Rowe; A J Munro
Journal:  J R Soc Med       Date:  1984-08       Impact factor: 5.344

6.  Recurrent, familial Reye-like syndrome with a new complex amino and organic aciduria.

Authors:  O N Elpeleg; E Christensen; H Hurvitz; D Branski
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

7.  The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia.

Authors:  A H Lockwood; J M McDonald; R E Reiman; A S Gelbard; J S Laughlin; T E Duffy; F Plum
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

8.  Interactions of aspirin and other potential etiologic factors in an animal model of Reye syndrome.

Authors:  D R Deshmukh; H F Maassab; M Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Liver lipid profiles of adults taking therapeutic doses of aspirin.

Authors:  J L Rabinowitz; D G Baker; T G Villanueva; A P Asanza; D M Capuzzi
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

Review 10.  Reye's syndrome: a clinical review.

Authors:  J F Crocker; P C Bagnell
Journal:  Can Med Assoc J       Date:  1981-02-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.